Power Moves: University of Maryland, Baltimore appoints new medical dean

Powerful moves is a section where we retrace the comings and goings of talents across the region. Got a new hire, gig, or promotion? Email us: [email protected].

UMB has a new Dean of Medicine

Dr. Mark T. Gladwin was named the new dean of the University of Maryland School of Medicine to University of Maryland, Baltimore.

“The search committee was impressed not only with his background, but also with his vision for the future of medicine and the role of medical school in today’s society,” said Dr. Claire M. FraserProfessor of Medicine and Director of Institute of Genome Sciences who chaired the search committee, in a statement.

As Dean, he will be responsible for upholding UMB’s core values ​​and promoting and enhancing diversity, equity, and inclusion at UMSOM while leading the progress and innovation in education, research and clinical care.

Gladwin brings his experience of University of Pittsburgh, where he chaired the Department of Medicine. In this work he supervised over 800 faculty members and was a prolific researcher (with over 470 manuscripts since 1996) in the fields of vascular biology and nitric oxide.

“I couldn’t be happier to announce that Dr. Gladwin will be the next Dean of the University of Maryland School of Medicine,” Dr. Bruce Jarrel, president of the UMB, said in a statement. “I am confident that he will continue to enrich the legacy of our medical school and position our world-class institution to meet the challenges of the future.”

Medcura appoints new CMO on the heels of Series A

Riverdale-based medical device company Medcura named Dr Kenneth Renkens as his chief physician. After the company’s $7.4 million Series A, this hire of a seasoned medical device vet shows the company’s willingness to scale.

“His determined style fits perfectly with our growing team and our surgical program,” said the CEO. larry tiffany said in a statement. “His expert advice on the clinical evaluation of surgical hemostats by Medcura will be critical to the success of our lead surgical product, as we bring a new class of reliable, easy-to-use hemostats to the operating room with a breakthrough price-to-use, in which we think could potentially be used in almost any surgical case.

Renkens is a neurosurgeon who previously co-founded Indiana Spine Group, a multi-specialty spine surgery practice. This experience will help guide Medcura as it evolves.

“I was impressed with recent published results demonstrating the efficacy and safety of Medcura’s fluid implantable technology in the treatment of severe traumatic injuries in the field,” Renkens said in a statement. “Combined with Medcura’s experience in providing its already FDA cleared technology for consumer use, I clearly saw a basis for clinical implementation in the [operating room]. I am excited to help this remarkable team achieve final preclinical evaluation of their lead surgical product which will support a registrational clinical trial in neuro, cardio and general surgical applications.

Dragos Appoints Operational Technology Cert Director

Hannover-based industrial cybersecurity company Draco appointed Dawn Capelli as Director of Operational Technology Certification. She will lead Dragos’ OT Cyber ​​Emergency Response Team (OT CERT) certification program, which will serve as a community resource center.

“I look forward to working with the exemplary management team at Dragos to build the new OT CERT into a world-class resource center that serves both Dragos customers and the wider ICS/OT community to improve security awareness and preparedness. industrial infrastructure,” Cappelli said in a statement. “I’m especially excited about providing resources to small and medium-sized businesses to protect their ICS environments. »

Cappelli has previous experience as director and founder of the Insider Threat Center CERT to Carnegie Mellon Universityit is Institute of Software Engineering.